European Commission approves first COVID-19 vaccine

The European Commission has approved the BioNTech/Pfizer vaccine, following the recommendation of the European Medicines Agency (EMA) for a conditional marketing authorisation. This applies to people over the age of 16.

The first COVID-19 vaccine is now available for use in the European Union. On Monday the European Commission approved the BioNTech/Pfizer vaccine for use. “Today we are adding an important chapter to our fight against COVID-19,” stressed European Commission President Ursula von der Leyen following the decision.

The approval was based on the relevant recommendation of the European Medicines Agency (EMA). A few hours earlier it had recommended authorising the BioNTech vaccine. EMA Executive Director Emer Cooke said it was a scientific breakthrough. A new vaccine for a novel disease has been developed within one year. Federal Health Minister Jens Spahn described the process as a “milestone in the fight against the pandemic”.

Safety is the top priority

The global effort has made it possible to develop a vaccine in an exceptionally short period of time. “This is really a historic scientific achievement,” said the EMA Executive Director. Every effort has been made to speed up the processes involved in developing and approving the vaccine, but the top priority has always been to ensure that the vaccine is safe. The vaccine, she said, fully complies with the EU’s rigorous standards regarding efficacy and safety. The recommendation applies to people over the age of 16. Commenting on the new variant of the virus that has been identified in the United Kingdom, for instance, Emer Cooke said that at this moment there is no evidence to suggest that the vaccine will not be effective against the new variant.

EMA: All data will be made public

The market approval involves an obligation for all EU states to provide all available data to the EMA to enable it to monitor safety. Emer Cooke said it is clear that a vaccine can only be effective if the people trust it. That is why all data will be made public and presented in a transparent manner.

The BioNTech/Pfizer vaccine is a first step, but more vaccines are needed, declared Emer Cooke, which is why the EMA is in contact with other vaccine developers. She said she was delighted to issue the recommendation that the first vaccine in Europe be approved. But it will still take time to conquer the pandemic. “That is why we must all do our best to force back the disease; we must consistently respect all hygiene rules,” she stressed.

On this topic

Videoconference of EU heads of state and government: “The news in recent days gives us a high degree of confidence”Internal link

The EU heads of state and government have held a videoconference to discuss steps to address the pandemic. They looked at vaccination and at the possibility of expanding the gateway that links national contact tracing and warning apps, like Germany’s Corona-Warn-App.

FAQ: What is the European Union doing about the COVID-19 pandemic?Internal link

The spread of the novel coronavirus is a challenge for states around the world. Member states of the EU have been particularly hard hit by the crisis. What are the EU institutions doing to stem the spread of the virus, provide medical care, and mitigate the economic consequences of the pandemic?

Europe's response to the COVID-19 pandemic: Emerging from the crisis – together and in a coordinated fashionInternal link

The coronavirus pandemic is one of the greatest global challenges of our times. It has underscored the fact that European nations can only conquer such a challenge when they work together towards a common goal.